Moshkelgosha

the best has yet to come!

Long
Moshkelgosha Updated   
NASDAQ:VBIV   VBI Vaccines, Inc.
They have a project to develop a polyvalent vaccine for SARS, MERS, and COVID-19. IF they could develop it, they will be the winner of this game by far!
Comment:
More than 10% since published today!
Comment:
2.2, 2.4, and 2.8 are the most important resistance levels!
Comment:
FIRST TARGET ZONE REACHED MUCH SOONER THAN EXPECTED!>50% IN A WEEK!
Trade closed: target reached

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.